https://www.thebodypro.com/category/adverse-events-comorbidities-hiv/tag/blood-disorders

The Latest

pulmonary embolism

Study Finds Higher Risk of Recurring Blood Clots Among Some People Living With HIV

However, the findings need to be studied in larger, more diverse populations.

By Barbara Jungwirth
woman with doctor looking at prescription bottle

This Week in HIV Research: Every Prescription Can Use a Good Steward

Sept. 19, 2019: HIV antiretroviral stewardship plans in hospitals can save money -- and lives; demographic correlates of PrEP interruption; HIV and atrial fibrillation risk; cytopenias common, despite viral suppression.

By Barbara Jungwirth and Myles Helfand
NHS hospital

More Than 30 Years Later, the UK Government Opens Inquiry Into Blood Contaminated With HIV and Hepatitis C

On Sept. 24, the first widespread inquiry into how thousands of people in the United Kingdom received contaminated blood in the 1970s and 1980s began with a preliminary hearing and a commemoration event dedicated to the victims.

By Martha Kempner
Promo Image

USA Today Examines HIV/AIDS Among Hemophiliacs, History of Virus in U.S. Blood Supply

USA Today on Wednesday examined HIV/AIDS among hemophiliacs and the history of the virus in the U.S. blood supply. Hemophilia, a condition in which a person's blood does not clot normally, mostly occurs in men, and hemophiliacs need transfusions of c...

By Henry J. Kaiser Family Foundation
Promo Image

Study Finds Epoetin Alfa Improves Anemia in HIV/HCV-Coinfected Patients

Guidelines for HIV/hepatitis C virus (HCV)-coinfected patients recommend HCV treatment with pegylated interferon-alfa (PEG-IFN) plus ribavirin (RBV). The adverse effects of IFN/RBV, particularly anemia, may be more common among HIV/HCV-coinfected tha...

By International Association of Physicians in AIDS Care
Promo Image

Incidence of Zidovudine-Associated Anemia May Be Lower Than Initially Thought -- Particularly With Fixed-Dose Combinations

In the beginning, there was zidovudine (AZT, Retrovir). As the first antiretroviral drug approved for the treatment of HIV, its benefits during the early years of the epidemic were incalculable. However, zidovudine's use also had at least one downsid...

By Mark Wainberg, Ph.D.
Promo Image

HIV/AIDS Anemia: Prevalence and Severity of Anemia Increases With Advancing HIV Disease

The current study describes the prevalence of anemia, a common hematologic abnormality that can significantly impact clinical outcomes and quality of life (QOL), in several populations of patients with HIV. Specifically, P.S. Belperio and colleagues ...

By CDC National Prevention Information Network
Promo Image

Longer Dosing Intervals of Epoetin Alfa Are Effective in Maintaining Hemoglobin Levels in Anemic, HIV-Infected Patients

Introduction

Anemia, defined as a reduction below normal in the number of red blood cells or quantity of hemoglobin, has long been recognized as an important clinical problem in HIV disease. It remains the most frequent blood-related complication in...

By Bob Frascino, M.D.
Promo Image

New Hemophilia Treatment Has Virtually No HIV Transmission Risk

Last week, FDA approved Advate, a hemophilia A treatment containing no human blood components. The drug will be available in pharmacies within two to five weeks. Baxter Healthcare Corp., the drug's developer, has not determined its average wholesale ...

By CDC National Prevention Information Network
Promo Image

Mild to Moderate Anemia Remains Common in HIV Patients

Anemia Prevalence Among HIV Patients: Antiretroviral Therapy and Other Risk Factors (Poster 1151) Authored by J.P. Nadler, T.S. Wills, C. Somboonwit, A. Vincent, G. Leitz, K. Marino, E. Naik, S. Powers, N. Khan, N. Almyroudis, B. Laartz

Introd...

By Bob Frascino, M.D.